Legal Opinion
In Re: Stepan Company
Court of Appeals for the Federal Circuit
Decided August 25, 2017No. 2016-1811PublishedCited by 8 opinions
1Opinion of the Court
Opinion for the court filed by
Circuit Judge MOORE.
Stepan Company (“Stepan”) appeals from a decision of the Patent Trial and Appeal Board (“Board”) affirming the examiner’s rejection of claims 1-31 of U.S. Patent Application No. 12/456,567 (“the ’567 application”). For the reasons discussed below, we vacate and remand.
Background
The ’567 application is directed to herbicidal formulations containing glyphosate salt with a surfactant system.'Surfactants can enhance glyphosate’s effectiveness as' an herbicide by providing better adherence to leaves, thereby enhancing penetration. According to the…
2Cases cited8 opinions
- Burlington Truck Lines, Inc. v. United StatesSupreme Court of the United States · 1962
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- In Re Sang-Su LeeCourt of Appeals for the Federal Circuit · 2002
- Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd.Court of Appeals for the Federal Circuit · 2016
- Medichem, S.A. v. Rolabo, S.L.Court of Appeals for the Federal Circuit · 2006
3 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Osi Pharmaceuticals, LLC v. Apotex Inc.Court of Appeals for the Federal Circuit · 2019
- University of California v. Broad Institute, Inc.Court of Appeals for the Federal Circuit · 2018
- Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc.Court of Appeals for the Federal Circuit · 2018
- Adapt Pharma Operations v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2022
- Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc.Court of Appeals for the Federal Circuit · 2018
3 more not listed; retrieve them via the Exa API.